Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health ... marking a milestone in the study of new-generation weight-loss drugs such as Ozempic, ...

In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...

Oprah Winfrey admitted two years ago to taking diabetes medication to lose weight. Now, in a new podcast episode, she ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...